Skip to main content
Top

2014 | OriginalPaper | Chapter

16. Phylogenetic Cladograms: Tools for Analyzing Biomedical Data

Authors : Mones S. Abu-Asab, Jim DeLeo

Published in: Springer Handbook of Bio-/Neuroinformatics

Publisher: Springer Berlin Heidelberg

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This chapter provides an introduction to phylogenetic cladograms – a systems biology evolutionary-based computational methodology that emphasizes the importance of considering multilevel heterogeneity in living systems when mining data related to these systems. We start by defining intelligence as the ability to predict, because prediction is a very important objective in mining data, especially biomedical data (Sect. 16.1). We then give a brief review of artificial intelligence (AI) and computational intelligence (CI) (Sects. 16.2, 16.3), provide a conciliatory overview of CI, and suggest that phylogenetic cladograms which provide hypotheses about speciation and inheritance relationships should be considered to be a CI methodology. We then discuss heterogeneity in biomedical data and talk about data types, how statistical methods blur heterogeneity, and the different results obtained between more traditional CI methodologies (phenetic) and phylogenetic techniques. Finally, we give an example of constructing and interpreting a phylogenetic cladogram tree.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
16.1.
go back to reference M.S. Abu-Asab, M. Chaouchi, S. Alesci, S. Galli, M. Laassri, A.K. Cheema, F. Atouf, J. VanMeter, H. Amri: Biomarkers in the age of omics: Time for a systems biology approach, OMICS 15(3), 105–112 (2011)CrossRef M.S. Abu-Asab, M. Chaouchi, S. Alesci, S. Galli, M. Laassri, A.K. Cheema, F. Atouf, J. VanMeter, H. Amri: Biomarkers in the age of omics: Time for a systems biology approach, OMICS 15(3), 105–112 (2011)CrossRef
16.2.
go back to reference H.H. Heng, G. Liu, J.B. Stevens, S.W. Bremer, K.J. Ye, B.Y. Abdallah, S.D. Horne, C.J. Ye: Decoding the genome beyond sequencing: The new phase of genomic research, Genomics 98(4), 242–252 (2011)CrossRef H.H. Heng, G. Liu, J.B. Stevens, S.W. Bremer, K.J. Ye, B.Y. Abdallah, S.D. Horne, C.J. Ye: Decoding the genome beyond sequencing: The new phase of genomic research, Genomics 98(4), 242–252 (2011)CrossRef
16.3.
go back to reference L. Hood, J.R. Heath, M.E. Phelps, B. Lin: Systems biology and new technologies enable predictive and preventative medicine, Science 306(5696), 640–643 (2004)CrossRef L. Hood, J.R. Heath, M.E. Phelps, B. Lin: Systems biology and new technologies enable predictive and preventative medicine, Science 306(5696), 640–643 (2004)CrossRef
16.4.
go back to reference M. Eklund, O. Spjuth, J.E. Wikberg: An eScience-Bayes strategy for analyzing omics data, BMC Bioinformatics 11, 282 (2010)CrossRef M. Eklund, O. Spjuth, J.E. Wikberg: An eScience-Bayes strategy for analyzing omics data, BMC Bioinformatics 11, 282 (2010)CrossRef
16.5.
go back to reference A. Galvan, J.P. Ioannidis, T.A. Dragani: Beyond genome-wide association studies: Genetic heterogeneity and individual predisposition to cancer, Trends Genetics 26(3), 132–141 (2010)CrossRef A. Galvan, J.P. Ioannidis, T.A. Dragani: Beyond genome-wide association studies: Genetic heterogeneity and individual predisposition to cancer, Trends Genetics 26(3), 132–141 (2010)CrossRef
16.6.
go back to reference M.S. Abu-Asab, H. Amri: Analyzing heterogeneous complexity in CAM research: A systems biology solution through parsimony phylogenetics, Forsch. Komplementärmed./Res. Complement. Med. 19(1), 42–48 (2012)CrossRef M.S. Abu-Asab, H. Amri: Analyzing heterogeneous complexity in CAM research: A systems biology solution through parsimony phylogenetics, Forsch. Komplementärmed./Res. Complement. Med. 19(1), 42–48 (2012)CrossRef
16.7.
go back to reference C.L. Sawyers: The cancer biomarker problem, Nature 452(7187), 548–552 (2008)CrossRef C.L. Sawyers: The cancer biomarker problem, Nature 452(7187), 548–552 (2008)CrossRef
16.8.
go back to reference F. Davidoff: Heterogeneity is not always noise: Lessons from improvement, JAMA 302(23), 2580–2586 (2009)CrossRef F. Davidoff: Heterogeneity is not always noise: Lessons from improvement, JAMA 302(23), 2580–2586 (2009)CrossRef
16.9.
go back to reference M. Abu-Asab, M. Chaouchi, H. Amri: Evolutionary medicine: A meaningful connection between omics, disease, treatment, Proteomics Clin. Appl. 2(2), 122–134 (2008)CrossRef M. Abu-Asab, M. Chaouchi, H. Amri: Evolutionary medicine: A meaningful connection between omics, disease, treatment, Proteomics Clin. Appl. 2(2), 122–134 (2008)CrossRef
16.11.
go back to reference M.L. Minsky: The Emotion Machine (Simon Schuster, New York 2006) M.L. Minsky: The Emotion Machine (Simon Schuster, New York 2006)
16.13.
go back to reference J. Searle: Minds, Brains and Programs, Behav. Brain Sci. 3(3), 417–457 (1980)CrossRef J. Searle: Minds, Brains and Programs, Behav. Brain Sci. 3(3), 417–457 (1980)CrossRef
16.14.
go back to reference J. Hawkins, S. Blakeslee: On Intelligence (Times Books, New York 2004) J. Hawkins, S. Blakeslee: On Intelligence (Times Books, New York 2004)
16.15.
go back to reference A.P. Engelbrecht: Computational Intelligence: An Introduction (Wiley, Hoboken 2002) A.P. Engelbrecht: Computational Intelligence: An Introduction (Wiley, Hoboken 2002)
16.16.
go back to reference I. Guyon: Feature Extraction: Foundations and Applications, Studies in Fuzziness and Soft Computing (Springer, Berlin, Heidelberg 2006)CrossRef I. Guyon: Feature Extraction: Foundations and Applications, Studies in Fuzziness and Soft Computing (Springer, Berlin, Heidelberg 2006)CrossRef
16.17.
go back to reference V.S. Cherkassky, F. Mulier: Learning from Data: Concepts, Theory, Methods, 2nd edn. (Wiley-Interscience, Hoboken 2007)CrossRefMATH V.S. Cherkassky, F. Mulier: Learning from Data: Concepts, Theory, Methods, 2nd edn. (Wiley-Interscience, Hoboken 2007)CrossRefMATH
16.18.
go back to reference R. Xu, D.C. Wunsch: Clustering, IEEE Press Series on Computation Intelligence (Wiley, Hoboken 2009) R. Xu, D.C. Wunsch: Clustering, IEEE Press Series on Computation Intelligence (Wiley, Hoboken 2009)
16.19.
go back to reference J.M. DeLeo: Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty, Proc. 2nd Int. Symp. Uncertain. Modeling Anal. (1993) J.M. DeLeo: Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty, Proc. 2nd Int. Symp. Uncertain. Modeling Anal. (1993)
16.20.
go back to reference J.E. Dayhoff, J.M. DeLeo: Artificial neural networks: Opening the black box, Cancer 91(8), 1615–1635 (2001)CrossRef J.E. Dayhoff, J.M. DeLeo: Artificial neural networks: Opening the black box, Cancer 91(8), 1615–1635 (2001)CrossRef
16.21.
go back to reference G.H. Heppner, B.E. Miller: Tumor heterogeneity: Biological implications and therapeutic consequences, Cancer Metastasis Rev. 2(1), 5–23 (1983)CrossRef G.H. Heppner, B.E. Miller: Tumor heterogeneity: Biological implications and therapeutic consequences, Cancer Metastasis Rev. 2(1), 5–23 (1983)CrossRef
16.22.
go back to reference F. Michor, K. Polyak: The origins and implications of intratumor heterogeneity, Cancer Prev. Res. 3(11), 1361–1364 (2010)CrossRef F. Michor, K. Polyak: The origins and implications of intratumor heterogeneity, Cancer Prev. Res. 3(11), 1361–1364 (2010)CrossRef
16.23.
go back to reference K. Puniyani, S. Kim, E.P. Xing: Multi-population GWA mapping via multi-task regularized regression, Bioinformatics 26(12), i208–i216 (2010)CrossRef K. Puniyani, S. Kim, E.P. Xing: Multi-population GWA mapping via multi-task regularized regression, Bioinformatics 26(12), i208–i216 (2010)CrossRef
16.24.
go back to reference J.J. Berman: Precancer: The beginning and the End of Cancer (Jones Bartlett, Sudbury 2010) J.J. Berman: Precancer: The beginning and the End of Cancer (Jones Bartlett, Sudbury 2010)
16.25.
go back to reference W. Liu, W. Zhao, M.L. Shaffer, N. Icitovic, G.A. Chase: Modelling clinical trials in heterogeneous samples, Stat. Med. 24(18), 2765–2775 (2005)MathSciNetCrossRef W. Liu, W. Zhao, M.L. Shaffer, N. Icitovic, G.A. Chase: Modelling clinical trials in heterogeneous samples, Stat. Med. 24(18), 2765–2775 (2005)MathSciNetCrossRef
16.26.
go back to reference H.H. Heng, S.W. Bremer, J.B. Stevens, K.J. Ye, G. Liu, C.J. Ye: Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective, J. Cell Physiol. 220(3), 538–547 (2009)CrossRef H.H. Heng, S.W. Bremer, J.B. Stevens, K.J. Ye, G. Liu, C.J. Ye: Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective, J. Cell Physiol. 220(3), 538–547 (2009)CrossRef
16.27.
go back to reference J. McClellan, M.C. King: Genetic heterogeneity in human disease, Cell 141(2), 210–217 (2010)CrossRef J. McClellan, M.C. King: Genetic heterogeneity in human disease, Cell 141(2), 210–217 (2010)CrossRef
16.28.
go back to reference M.M. Holland, M.R. McQuillan, K.A. OʼHanlon: Second generation sequencing allows for mtDNA mixture deconvolution and high resolution detection of heteroplasmy, Croat. Med. J. 52(3), 299–313 (2011)CrossRef M.M. Holland, M.R. McQuillan, K.A. OʼHanlon: Second generation sequencing allows for mtDNA mixture deconvolution and high resolution detection of heteroplasmy, Croat. Med. J. 52(3), 299–313 (2011)CrossRef
16.30.
go back to reference W. Liu, N. Icitovic, M.L. Shaffer, G.A. Chase: The impact of population heterogeneity on risk estimation in genetic counseling, BMC Med. Genetics 5, 18 (2004)CrossRef W. Liu, N. Icitovic, M.L. Shaffer, G.A. Chase: The impact of population heterogeneity on risk estimation in genetic counseling, BMC Med. Genetics 5, 18 (2004)CrossRef
16.31.
go back to reference M.S. Abu-Asab, M. Chaouchi, H. Amri: Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens, OMICS 12(3), 183–199 (2008)CrossRef M.S. Abu-Asab, M. Chaouchi, H. Amri: Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens, OMICS 12(3), 183–199 (2008)CrossRef
16.32.
go back to reference K. Hotakainen, U.H. Stenman: Will emerging prostate cancer markers redeem themselves?, Clin. Chem. 56(8), 1212–1213 (2010)CrossRef K. Hotakainen, U.H. Stenman: Will emerging prostate cancer markers redeem themselves?, Clin. Chem. 56(8), 1212–1213 (2010)CrossRef
16.33.
go back to reference R. Jones: Biomarkers: Casting the net wide, Nature 466(7310), S11–S12 (2010)CrossRef R. Jones: Biomarkers: Casting the net wide, Nature 466(7310), S11–S12 (2010)CrossRef
16.34.
go back to reference M. May: Biomarkers still off the mark for detecting breast cancer, Nat. Med. 16(1), 3 (2010)CrossRef M. May: Biomarkers still off the mark for detecting breast cancer, Nat. Med. 16(1), 3 (2010)CrossRef
16.35.
16.36.
go back to reference J. Lyons-Weiler, S. Patel, M.J. Becich, T.E. Godfrey: Tests for finding complex patterns of differential expression in cancers: Towards individualized medicine, BMC Bioinformatics 5, 110 (2004)CrossRef J. Lyons-Weiler, S. Patel, M.J. Becich, T.E. Godfrey: Tests for finding complex patterns of differential expression in cancers: Towards individualized medicine, BMC Bioinformatics 5, 110 (2004)CrossRef
16.37.
go back to reference R. Xu, S. Damelin, B. Nadler, D.C. Wunsch 2nd: Clustering of high-dimensional gene expression data with feature filtering methods and diffusion maps, Artif. Intell. Med. 48(2-3), 91–98 (2010)CrossRef R. Xu, S. Damelin, B. Nadler, D.C. Wunsch 2nd: Clustering of high-dimensional gene expression data with feature filtering methods and diffusion maps, Artif. Intell. Med. 48(2-3), 91–98 (2010)CrossRef
16.38.
go back to reference M. Abu-Asab, M. Chaouchi, H. Amri: Phyloproteomics: What phylogenetic analysis reveals about serum proteomics, J. Proteome Res. 5(9), 2236–2240 (2006)CrossRef M. Abu-Asab, M. Chaouchi, H. Amri: Phyloproteomics: What phylogenetic analysis reveals about serum proteomics, J. Proteome Res. 5(9), 2236–2240 (2006)CrossRef
16.39.
go back to reference R.S. Varghese, H.W. Ressom: LC-MS data analysis for differential protein expression detection, Methods Mol. Biol. 694, 139–150 (2011)CrossRef R.S. Varghese, H.W. Ressom: LC-MS data analysis for differential protein expression detection, Methods Mol. Biol. 694, 139–150 (2011)CrossRef
16.40.
go back to reference H. Tsugawa, Y. Tsujimoto, M. Arita, T. Bamba, E. Fukusaki: GC/MS based metabolomics: Development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA), BMC Bioinformatics 12, 131 (2011)CrossRef H. Tsugawa, Y. Tsujimoto, M. Arita, T. Bamba, E. Fukusaki: GC/MS based metabolomics: Development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA), BMC Bioinformatics 12, 131 (2011)CrossRef
16.41.
go back to reference B.A. Goldstein, A.E. Hubbard, A. Cutler, L.F. Barcellos: An application of Random Forests to a genome-wide association dataset: Methodological considerations & new findings, BMC Genetics 11, 49 (2010)CrossRef B.A. Goldstein, A.E. Hubbard, A. Cutler, L.F. Barcellos: An application of Random Forests to a genome-wide association dataset: Methodological considerations & new findings, BMC Genetics 11, 49 (2010)CrossRef
16.42.
go back to reference A. Thakur, V. Mishra, S.K. Jain: Feed forward artificial neural network: Tool for early detection of ovarian cancer, Sci. Pharm. 79(3), 493–505 (2011)CrossRef A. Thakur, V. Mishra, S.K. Jain: Feed forward artificial neural network: Tool for early detection of ovarian cancer, Sci. Pharm. 79(3), 493–505 (2011)CrossRef
16.43.
go back to reference J. Felsenstein: Inferring Phylogenies (Sinauer, Sunderland 2004) J. Felsenstein: Inferring Phylogenies (Sinauer, Sunderland 2004)
16.44.
go back to reference W. Hennig: Phylogenetic systematics (Univ. of Illinois Press, Urbana 1966) W. Hennig: Phylogenetic systematics (Univ. of Illinois Press, Urbana 1966)
16.45.
go back to reference R. Eck, M. Dayhoff: Atlas of Protein Sequence and Structure (National Biomedical Research Foundation, Silver Spring 1966) R. Eck, M. Dayhoff: Atlas of Protein Sequence and Structure (National Biomedical Research Foundation, Silver Spring 1966)
16.46.
go back to reference J. Camin, R. Sokal: A method for deducing branching sequences in phylogeny, Evolution 19, 311–326 (1965)CrossRef J. Camin, R. Sokal: A method for deducing branching sequences in phylogeny, Evolution 19, 311–326 (1965)CrossRef
16.47.
go back to reference S. Sridhar, F. Lam, G.E. Blelloch, R. Ravi, R. Schwartz: Direct maximum parsimony phylogeny reconstruction from genotype data, BMC Bioinformatics 8, 472 (2007)CrossRef S. Sridhar, F. Lam, G.E. Blelloch, R. Ravi, R. Schwartz: Direct maximum parsimony phylogeny reconstruction from genotype data, BMC Bioinformatics 8, 472 (2007)CrossRef
16.48.
go back to reference D. Stefankovic, E. Vigoda: Pitfalls of heterogeneous processes for phylogenetic reconstruction, Syst. Biol. 56(1), 113–124 (2007)CrossRef D. Stefankovic, E. Vigoda: Pitfalls of heterogeneous processes for phylogenetic reconstruction, Syst. Biol. 56(1), 113–124 (2007)CrossRef
16.49.
go back to reference D. Stefankovic, E. Vigoda: Phylogeny of mixture models: Robustness of maximum likelihood and non-identifiable distributions, J. Comput. Biol. 14(2), 156–189 (2007)MathSciNetCrossRef D. Stefankovic, E. Vigoda: Phylogeny of mixture models: Robustness of maximum likelihood and non-identifiable distributions, J. Comput. Biol. 14(2), 156–189 (2007)MathSciNetCrossRef
16.50.
go back to reference K. Graham, A. de las Morenas, A. Tripathi, C. King, M. Kavanah, J. Mendez, M. Stone, J. Slama, M. Miller, G. Antoine, H. Willers, P. Sebastiani, C.L. Rosenberg: Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile, Br. J. Cancer 102(8), 1284–1293 (2010)CrossRef K. Graham, A. de las Morenas, A. Tripathi, C. King, M. Kavanah, J. Mendez, M. Stone, J. Slama, M. Miller, G. Antoine, H. Willers, P. Sebastiani, C.L. Rosenberg: Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile, Br. J. Cancer 102(8), 1284–1293 (2010)CrossRef
16.52.
go back to reference D.H. Roukos: Mea Culpa with cancer-targeted therapy: New thinking and new agents design for novel, causal networks-based, personalized biomedicine, Expert Rev. Mol. Diagn. 9(3), 217–221 (2009)CrossRef D.H. Roukos: Mea Culpa with cancer-targeted therapy: New thinking and new agents design for novel, causal networks-based, personalized biomedicine, Expert Rev. Mol. Diagn. 9(3), 217–221 (2009)CrossRef
16.53.
go back to reference H.H. Heng, J.B. Stevens, S.W. Bremer, K.J. Ye, G. Liu, C.J. Ye: The evolutionary mechanism of cancer, J. Cell Biochem. 109(6), 1072–1084 (2010) H.H. Heng, J.B. Stevens, S.W. Bremer, K.J. Ye, G. Liu, C.J. Ye: The evolutionary mechanism of cancer, J. Cell Biochem. 109(6), 1072–1084 (2010)
16.54.
go back to reference J. Felsenstein: PHYLIP: Phylogeny inference package (version 3.2), Cladistics 5, 164–166 (1989) J. Felsenstein: PHYLIP: Phylogeny inference package (version 3.2), Cladistics 5, 164–166 (1989)
16.57.
go back to reference P.W. Ewald: An evolutionary perspective on parasitism as a cause of cancer, Adv. Parasitol. 68, 21–43 (2009)CrossRef P.W. Ewald: An evolutionary perspective on parasitism as a cause of cancer, Adv. Parasitol. 68, 21–43 (2009)CrossRef
16.58.
go back to reference D.J. Greig, F.M. Gulland, C.A. Rios, A.J. Hall: Hematology and serum chemistry in stranded and wild-caught harbor seals in central California: Reference intervals, predictors of survival, and parameters affecting blood variables, J. Wildl. Dis. 46(4), 1172–1184 (2010)CrossRef D.J. Greig, F.M. Gulland, C.A. Rios, A.J. Hall: Hematology and serum chemistry in stranded and wild-caught harbor seals in central California: Reference intervals, predictors of survival, and parameters affecting blood variables, J. Wildl. Dis. 46(4), 1172–1184 (2010)CrossRef
Metadata
Title
Phylogenetic Cladograms: Tools for Analyzing Biomedical Data
Authors
Mones S. Abu-Asab
Jim DeLeo
Copyright Year
2014
DOI
https://doi.org/10.1007/978-3-642-30574-0_16

Premium Partner